新疆地区FGB基因多态性对纤维蛋白原水平及胆囊结石发病的影响
DOI: 10.3969/j.issn.1001-5256.2021.09.032
Effects of FGB gene polymorphism on fibrinogen level and gallstones incidence in Xinjiang, China
-
摘要:
目的 探讨纤维蛋白原β链(FGB)基因rs4220、rs1044291位点多态性与血浆纤维蛋白原(Fg)水平及胆囊结石的相关性。 方法 收集2017年12月—2020年5月在新疆维吾尔自治区人民医院住院治疗及健康体检的维吾尔族、汉族胆囊结石及非胆囊结石患者各150例,采集血液标本,测定血浆Fg水平,并在前期的FGB基因全外显子测序结果的基础上,选择FGB基因rs4220、rs1044291多态位点,采用SNaPshot法进行基因型鉴定。符合正态分布的计量资料2组间比较采用t检验,非正态分布的计量资料2组间比较采用Mann-Whitney U检验,计数资料组间比较采用χ2检验;各变量与胆囊结石的关系采用多因素logistic回归分析。 结果 在汉族人群中,胆囊结石组血浆Fg水平高于对照组,差异有统计学意义[2.90(2.43~3.49) g/L vs 2.47(2.06~3.02) g/L,Z=-3.62, P<0.01],而维吾尔族人群中无差异。FGB基因rs4220、rs1044291位点基因频率在维吾尔族、汉族胆囊结石组与对照组差异均无统计学意义(P值均>0.05);在汉族人群中,胆囊结石组rs4220位点GG基因型者血浆Fg水平高于对照组[2.84(2.32~3.61)g/L vs 2.34(2.05~2.75)g/L,Z=-3.04, P<0.05],rs1044291位点T基因型携带者Fg水平高于对照组[(3.08±0.75)g/L vs(2.48±0.48)g/L,t=2.80, P<0.05)]。在维吾尔族人群中,胆囊结石组与对照组间比较,仅有rs4220位点的A基因携带者血浆Fg水平低于对照组[2.84(2.08~3.06)g/L vs 3.10(2.85~3.98)g/L,Z=-2.41, P<0.05]。但两个民族胆囊结石组、对照组内,各基因型携带者Fg水平差异均无统计学意义(P值均>0.05)。 结论 FGB基因多态性对血浆Fg水平的影响可能与种族有关;FGB基因rs4220、rs1044291位点多态性可能通过调控Fg水平影响新疆人群胆囊结石的发病。 -
关键词:
- 胆囊结石病 /
- 纤维蛋白原 /
- 多态现象, 遗传 /
- 新疆[维吾尔自治区]
Abstract:Objective To investigate the association of the polymorphisms of the FGB gene rs4220 and rs1044291 loci with plasma fibrinogen (Fg) level and gallstones in Xinjiang, China. Methods Blood samples were collected from 150 Uygur and Han patients with gallstones and 150 Uygur and Han individuals without gallstones who were hospitalized or underwent physical examination in The People's Hospital of Xinjiang Uygur Autonomous Region from December 2017 to May 2020. Plasma Fg level was measured, and based on the previous results of whole exon sequencing of the FGB gene, the SNaPshot method was used to identify the genotype at rs4220 and rs1044291 loci of the FGB gene. The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups; a multivariate logistic regression analysis was used to investigate the association between each variable and gallstones. Results For the Chinese Han population, the gallstones group had a significantly higher plasma Fg level than the control group [2.90 (2.43-3.49) g/L vs 2.47 (2.06-3.02) g/L, Z=-3.62, P < 0.01), while there was no significant difference in the Uyghur population. There were no significant differences in the frequencies of genotypes and alleles at the rs4220 and rs1044291 loci of the FGB gene between the gallstones group and the control group in both Uyghur and Han populations (all P > 0.05). For the Chinese Han population, the subjects carrying GG genotype at the rs4220 locus in the gallstones group had a significantly higher plasma Fg level than those in the control group [2.84(2.32-3.61) g/L vs 2.34(2.05-2.75) g/L, Z=-3.04, P < 0.05], and the subjects carrying T genotype at the rs1044291 locus had a significantly higher plasma Fg level than those in the control group (3.08±0.75 g/L vs 2.48±0.48 g/L, t=2.80, P < 0.05). For the Uyghur population, only the subjects carrying A genotype at the rs4220 locus in the gallstones group had a significantly lower plasma Fg level than those in the control group [2.84(2.08-3.06) g/L vs 3.10(2.85-3.98) g/L, Z=-2.41, P < 0.05]. There was no significant difference in plasma Fg level between the subjects carrying different genotypes within the gallstones group or the control group for both Uyghur and Han populations (all P > 0.05). Conclusion The influence of FGB gene polymorphism on plasma Fg level may be associated with race, and FGB gene polymorphisms at the rs4220 and rs1044291 loci may be involved in the pathogenesis of gallstones by regulating Fg level in the population in Xinjiang. -
Key words:
- Cholecystolithiasis /
- Fibrinogen /
- Polymorphism, Genetic /
- XINJIANG
-
表 1 PCR引物及单碱基延伸引物序列
位点 引物序列 延伸引物序列 rs4220 F-GCAGATACTACTGGGGTGGACA AAGGGGTCATGGTACTCAATGA R-AACTCCTGACCTTGTGACCG rs1044291 F-GTCCTCCACCCCTAATGTATCA TTTTTTTTTTTTTTTTTTTTAGGG R-CATTCACTGGCTCTGGGTCT CCTGACCTGTCCTGGAAT 表 2 研究对象的一般特征
民族 指标 胆囊结石组 对照组 统计值 P值 维吾尔族 例数 97 73 年龄(岁) 53.00(44.00~65.50) 50.00(39.50~60.50) Z=-1.61 0.108 收缩压(mm Hg) 129(121~143) 130(114~145) Z=-0.33 0.742 舒张压(mm Hg) 78.28±10.17 76.89±12.31 t=0.78 0.435 BMI(kg/m2) 27.34(24.68~30.59) 27.82(24.33~32.10) Z=-0.30 0.765 游离脂肪酸(mmol/L) 0.34(0.25~0.47) 0.29(0.22~0.43) Z=-1.33 0.185 TC(mmol/L) 4.41±0.86 4.63±1.27 t=-0.86 0.394 TG(mmol/L) 1.49±0.55 1.34±0.63 t=1.03 0.305 LDL-C(mmol/L) 2.58±0.76 2.69±1.03 t=-0.47 0.639 HDL-C(mmol/L) 1.10±0.36 1.25±0.38 t=-0.21 0.043 Fg(g /L) 2.74(2.52~3.18) 2.82(2.22~3.27) Z=-0.22 0.828 汉族 例数 51 76 年龄(岁) 58.76±14.28 55.92±16.07 t=1.02 0.309 收缩压(mm Hg) 131.39±21.25 131.38±18.08 t=0.003 0.998 舒张压(mm Hg) 74.16±11.83 78.88±10.98 t=-2.15 0.033 BMI(kg/m2) 25.63(23.18~28.37) 24.70(22.93~28.62) Z=-0.54 0.592 游离脂肪酸(mmol/L) 0.41(0.33~0.60) 0.33(0.20~0.49) Z=-2.60 0.009 TC(mmol/L) 4.09(3.63~4.57) 4.29(3.86~5.65) Z=-1.20 0.230 TG(mmol/L) 1.26(0.92~1.68) 1.36(0.84~2.23) Z=-0.42 0.673 LDL-C(mmol/L) 2.39(2.15~2.73) 2.58(2.10~3.20) Z=-0.56 0.576 HDL-C (mmol/L) 1.09±0.23 1.12±0.22 t=-0.42 0.680 Fg(g /L) 2.90(2.43~3.49) 2.47(2.06~3.02) Z=-3.62 0.000 表 3 胆囊结石组FGB基因rs4220、rs1044291位点分布频率Hardy-Weinberg平衡检验
组别 位点 基因型 实际频数 理论频数 χ2值 P值 胆囊结石组 rs4220 GG 99 98.3 0.116 0.944 GA 44 43.7 AA 4 5.0 rs1044291 CC 104 102.4 0.224 0.894 CT 40 36.7 TT 3 3.9 对照组 rs4220 GG 99 99.7 0.096 0.953 AG 44 44.3 AA 6 5.0 rs1044291 CC 109 106.6 0.253 0.881 CT 35 38.3 TT 5 4.1 表 4 FGB基因rs4220、rs1044291位点基因型分布
民族 位点 基因型/等位基因 胆囊结石组 对照组 χ2值 P值 维吾尔族 rs4220 GG 63(64.9%) 49(67.1%) 0.092 0.955 GA 31(32.0%) 22(30.1%) AA 3(3.1%) 2(2.7%) G 157(80.9%) 120(82.2%) 0.088 0.767 A 37(19.1%) 26(17.8%) rs1044291 CC 64(66.0%) 54(74.0%) 1.280 0.527 CT 30(30.9%) 17(23.3%) TT 3(3.1%) 2(2.7%) C 158(81.4%) 125(85.6%) 1.040 0.308 T 36(18.6%) 21(14.4%) 汉族 rs4220 GG 37(72.5%) 50(65.8%) 1.181 0.554 GA 13(25.5%) 22(28.9%) AA 1(2.0%) 4(5.3%) G 87(85.3%) 122(80.3%) 1.060 0.303 A 15(14.7%) 30(19.7%) rs1044291 CC 40(80.0%) 55(72.4%) 1.048 0.592 CT 9(18.0%) 18(23.7%) TT 1(2.0%) 3(3.9%) C 89(89.0%) 128(11.0%) 1.157 0.282 T 11(84.2%) 24(15.8%) 表 5 胆囊结石组与对照组中各基因型与血浆Fg水平的关系
民族 位点 基因型 Fg水平(g/L) 胆囊结石组 对照组 汉族 rs4220 GG 2.84(2.32~3.61)1) 2.34(2.05~2.75) AG+AA 3.10±0.64 2.67±0.66 rs1044291 CC 2.93(2.35~3.65) 2.89(2.24~3.32) CT+TT 3.08±0.751) 2.48±0.48 维吾尔族 rs4220 GG 2.68(2.35~3.21) 2.58(2.08~3.11) AG+AA 2.84(2.08~3.06)1) 3.10(2.85~3.98) rs1044291 CC 2.74(2.52~3.21) 2.89(2.24~3.32) CT+TT 2.79(2.48~3.09) 2.80(2.22~3.11) 注:与对照组比较,1)P < 0.05。 表 6 影响胆囊结石的危险因素分析
自变量 B值 SE P值 OR 95%CI 族别 0.590 0.241 0.014 1.804 1.125~2.893 Fg 0.052 0.025 0.042 1.053 1.002~1.107 -
[1] SONG J, CHEN LZ, ZHENG YY, et al. Correlation between β-fibrinogen gene-249 C / T polymorphism and coronary heart disease in Inner Mongolia[J]. J Baotou Med Coll, 2016, 32(8): 7-9. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX201608004.htm宋剑, 陈丽珠, 郑玉云, 等. 内蒙古地区人纤维蛋白原β-249 C/T基因多态性与冠心病的相关性[J]. 包头医学院学报, 2016, 32(8): 7-9. https://www.cnki.com.cn/Article/CJFDTOTAL-BTYX201608004.htm [2] LI JT, ZHAO HM, CHEN XH. Correlation between β-fibrinogen gene-455G/A polymorphism and plasma fibrinogen level and lacunar infraction[J]. Int J Cerebrovasc, 2019, 27(12): 902-908. DOI: 10.3760/cma.j.issn.1673-4165.2019.12.005.李军廷, 赵鸿梅, 陈晓虹. β-纤维蛋白原基因-455G/A多态性与血浆纤维蛋白原水平及腔隙性脑梗死的相关性[J]. 国际脑血管病杂志, 2019, 27(12): 902-908. DOI: 10.3760/cma.j.issn.1673-4165.2019.12.005. [3] QIN YL. The study of the relationships between the coagulo-fibrinolytic changes and the roles of fibrin(ogen) in cholesterol gallstone formation[D]. Nanjing: Southeast University, 2000.秦永林. 纤维蛋白(原)和凝血、纤溶系统在胆囊胆固醇结石形成中的作用[D]. 南京: 东南大学, 2000. [4] ZHU SZ. Therapeutic effect and related factors of human fibrinogen on traumat-ic traumatic coagulopathy[J]. Chin J Clin Pharmacol Ther, 2019, 24(6): 693-698. DOI: 10.12092/j.issn.1009-2501.2019.06.015.朱悚之. 人纤维蛋白原对急诊外伤致创伤性凝血病疗效及相关因素分析[J]. 中国临床药理学与治疗学, 2019, 24(6): 693-698. DOI: 10.12092/j.issn.1009-2501.2019.06.015. [5] FULLER GM, ZHANG Z. Transcriptional control mechanism of fibrinogen gene expression[J]. Ann N Y Acad Sci, 2001, 936: 469-479. DOI: 10.1111/j.1749-6632.2001.tb03534.x. [6] LIU CH, GE YL, LI LR, et al. Polymorphism of fibrinogen Bβ-249C / T gene in smokers with COPD[J]. J Bengbu Med Coll, 2020, 45(2): 201-204. DOI: 10. 13898/ j. cnki. issn. 1000-2200. 2020. 02. 017.刘聪辉, 戈艳蕾, 李丽蕊, 等. 慢性阻塞性肺疾病吸烟病人纤维蛋白原Bβ-249 C/T基因多态性[J]. 蚌埠医学院学报, 2020, 45(2): 201-204. DOI: 10. 13898/ j. cnki. issn. 1000-2200. 2020. 02. 017. [7] DUAN JL, ZHANG XM, MENG PF, et al. Relationship between plasma fibrinogen gene polymorphism, obesity and ischemic cerebral stroke[J]. Chin J Integr Med Cardio/Cerebrovasc Dis, 2020, 18(13): 2168-2171. DOI: 10.12102/ji.ssn.1672-1349.2020.13.040.段家乐, 张晓敏, 孟鹏飞, 等. 血浆纤维蛋白原基因多态性、肥胖与缺血性脑卒中的关系探讨[J]. 中西医结合心脑血管病杂志, 2020, 18(13): 2168-2171. DOI: 10.12102/ji.ssn.1672-1349.2020.13.040. [8] ONG KL, TSO AW, CHERNY SS, et al. A genetic variant in the gene encoding fibrinogen beta chain predicted development of hypertension in Chinese men[J]. Thromb Haemost, 2010, 103(4): 728-735. DOI: 10.1160/TH09-10-0692. [9] THEODORAKI EV, NIKOPENSIUS T, SUHORUTSENKO J, et al. Fibrinogen beta variants confer protection against coronary artery disease in a Greek case-control study[J]. BMC Med Genet, 2010, 11: 28. DOI: 10.1186/1471-2350-11-28. [10] INGEBRIGTSEN TS, MAROTT JL, RODE L, et al. Fibrinogen and α1-antitrypsin in COPD exacerbations[J]. Thorax, 2015, 70(11): 1014-1021. DOI: 10.1136/thoraxjnl-2015-207561. [11] STINTON LM, MYERS RP, SHAFFER EA. Epidemiology of gallstones[J]. Gastroenterol Clin North Am, 2010, 39(2): 157-169, vii. DOI: 10.1016/j.gtc.2010.02.003. [12] MIAO YG, XUE DB, ZHANG WH. Progress of research on the causes and treatment of Cholesterol Gallstones[J]. J Hepatopancreatobiliary Surg, 2016, 28(2): 155-157, 177. DOI: 10.11952/j.issn.1007-1954.2016.02.023.苗彦国, 薛东波, 张伟辉. 胆囊胆固醇结石成因及其治疗研究进展[J]. 肝胆胰外科杂志, 2016, 28(2): 155-157, 177. DOI: 10.11952/j.issn.1007-1954.2016.02.023. [13] LI WD. Epidemiological analysis of gallstone in Xinjiang[J]. Contemp Med Forum, 2014, 21: 187-188. https://www.cnki.com.cn/Article/CJFDTOTAL-QYWA201421157.htm李卫东. 对新疆地区胆囊结石的流行病学分析[J]. 当代医药论丛, 2014, 21: 187-188. https://www.cnki.com.cn/Article/CJFDTOTAL-QYWA201421157.htm [14] BODMER M, BRAUCHLI YB, KRÄHENBÜHL S, et al. Statin use and risk of gallstone disease followed by cholecystectomy[J]. JAMA, 2009, 302(18): 2001-2007. DOI: 10.1001/jama.2009.1601. [15] ZHUANG JH, DILIMULATI, ZHOU GM, et al. Clinical analysis of 872 cases of cholelithiasis in Xinjiang[J]. J Hepatopancreatobiliary Surg, 2006, 18(1): 47-48. DOI: 10.11952/j.issn.1007-1954.2006.01.018.庄建华, 地里木拉提, 周贵明, 等. 新疆维吾尔族聚居区居民胆结石872例临床分析[J]. 肝胆胰外科杂志, 2006, 18(1): 47-48. DOI: 10.11952/j.issn.1007-1954.2006.01.018. [16] CANSECO-AVILA LM, LOPEZ-ROBLERO A, SERRANO-GUZMAN E, et al. Polymorphisms-455G/A and-148C/T and fibrinogen plasmatic level as risk markers of coronary disease and major adverse cardiovascular events[J]. Dis Markers, 2019, 2019: 5769514. DOI: 10.1155/2019/5769514. [17] CRONJÉ HT, NIENABER-ROUSSEAU C, ZANDBERG L, et al. Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations[J]. PLoS One, 2017, 12(11): e0187712. DOI: 10.1371/journal.pone.0187712.
计量
- 文章访问数: 374
- HTML全文浏览量: 127
- PDF下载量: 28
- 被引次数: 0